Allosteric regulation of αIIbβ3 by β3 95-105

Thrombosis and Haemostasis

Volumn 99, Issue 4, 2008, Pages 701-710

  Haas, Thomas A ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Antiaggregatory agents; Fibrinogen binding; GPIIb IIIa inhibitors; Platelet activation inhibitors

Indexed keywords

FIBRINOGEN; INTEGRIN ALPHA2B BETA3 RECEPTOR; INTEGRIN RECEPTOR;

ALLOSTERISM; AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ARTICLE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS; THROMBOCYTE AGGREGATION;

ALLOSTERIC REGULATION; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY AFFINITY; BINDING SITES; HUMANS; INTEGRIN BETA3; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN STRUCTURE, TERTIARY; RABBITS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 43749122810     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-10-0645     Document Type: Article

References (39)

1. 3 and its antagonism at the new millennium. Thromb Haemost 2001; 86: 34-40.
2. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
3. Hughes PE, Pfaff M. Integrin affinity modulation. Trends Cell Biol 1998; 8: 359-364.
4. O'Toole TE, Katagiri Y, Faull RJ, et al. Integrin cytoplasmic domains mediate inside-out signal transduction. J Cell Biol 1994; 124: 1047-1059.
5. 3. Thromb Haemost 1997; 78: 220-225.
6. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex. Thromb Haemost 1994; 72: 1-15.
7. Bennett JS. The molecular biology of platelet membrane proteins. Semin Hematol 1990; 27: 186-204.
8. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
9. Ginsberg MH, Xiaoping D, O'Toole TE, et al. Platelet integrins. Thromb Haemost 1993; 70: 87-93.
10. IIb-subunit. Proc Natl Acad Sci USA 2000; 97: 1450-1455.
11. 3 "inside-out" activation as regulated by its cytoplasmic face. Cell 2002; 110: 587-597.
12. IIb independently activates platelet aggregation and thromboxane synthesis. J Biol Chem 1998; 273: 20317-20322.
13. Haas TA. Discrete functional motifs reside within the cytoplasmic tail of αV integrin subunit. Thromb Haemost 2008; 99: 96-107.
14. 3. Science 2001; 294: 339-345.
15. 3 in complex with an Arg-Gly-Asp ligand. Science 2002; 296: 151-155.
16. Xiao T, Takagi J, Coller BS, et al. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 2004; 432: 59-65.
17. Mould AP, Barton SJ, Askari JA, et al. Conformational changes in the integrin βA domain provide a mechanism for signal transduction via hybrid domain movement. J Biol Chem 2003; 278: 17028-17035.
18. Luo BH, Strokovich K, Walz T, et al. Allosteric β1 integrin antibodies that stabilize the low affinity state by preventing the swing-out of the hybrid domain. J Biol Chem 2004; 279: 27466-27471.
19. Takagi J, Petre BM, Walz T, et al. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 2002; 110: 599-611.
20. Hawiger J, Timmons S. Binding of fibrinogen and von Willebrand Factor to platelet glycoprotein IIb-IIIa complex. Methods Enzymol 1992; 215: 228-243.
21. Plow EF, Pierschbacher MD, Ruoslahti E, et al. Arginyl-Glycyl-Aspartic acid sequences and fibrinogen binding to platelets. Blood 1987; 70: 110-115.
22. Loftus JC, Smith JW, Ginsberg MH. Integrin-mediated cell adhesion: the extracellular face. J Biol Chem 1994; 269: 25235-25238.
23. Yamanouchi J, Hato T, Tamura T, et al. Identification of critical residues for ligand binding in the integrin β3 I-domain by site-directed mutagenesis. Thromb Haemost 2002; 87: 756-762.
24. 3 receptor function. Thromb Haemost 2003; 90: 853-862.
25. 3 are clustered in the β-propeller model. J Biol Chem 2001; 276: 44275-44283.
26. IIb subunit. Thromb Haemost 2004; 91: 111-118.
27. 3. Thromb Haemost 2004; 92: 1092-1098.
28. 3 subunit: cation displacement is involved in ligand binding. Cell 1994; 79: 659-667.
29. Humphries MJ. Integrin structure. Biochem Soc Trans 2000; 28: 311-339.
30. Charo IF, Nannizzi L, Phillips DR, et al. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 1991; 266: 1415-1421.
31. 3- integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia. Blood 2003; 101: 937-942.
32. 3 integrin subunit. J Biol Chem 2002; 277: 11126-11134.
33. 3: a ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem 1996; 271: 6017-6026.
34. 3. J Biol Chem 2000; 275: 7249-7260.
35. Ruse CI, Willard B, Haas TA, et al. Quantitative dynamics of site-specific protein phosphorylation determined using liquid chromatography electrospray ionization mass spectrometry. Anal Chem 2001; 74: 1658-1664.
36. 3 and elicit different functional responses. J Biol Chem 1999; 274: 16923-16932.
37. Haas TA, Bastida E, Nakamura K, et al. Binding of 13-HODE and 5-,12-,15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim Biophys Acta 1988; 961: 153-159.
38. Haas TA, Plow EF. Development of a structural model for the cytoplasmic domain of an integrin. Protein Eng 1997; 10: 1395-1405.
39. 3 (GPIIb/IIIa) antagonists. Arterioscler Thromb Vasc Biol 2007; 27: e9-15.